Biomarkers as Intermediate End Points in Chemoprevention Trials

4 April 1990

journal article
clinical trial
Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute

Vol. 82 (7), 555-560
https://doi.org/10.1093/jnci/82.7.555

Abstract

Scott M. Lippman, Jin S. Lee, Reuben Lotan, Walter Hittelman, Michael J. Wargovich, Waun K. Hong; Biomarkers as Intermediate End Points in Chemoprevention Tria

Keywords

BIOMARKERS
LEE
WAUN
JIN
LIPPMAN
INTERMEDIATE END POINTS
WARGOVICH
POINTS IN CHEMOPREVENTION

Cited by 149 articles